Insight Molecular Diagnostics Inc. Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Lease Obligation
Insight Molecular Diagnostics Inc. (IMDX) had Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Lease Obligation of $495.00 thousand as of 2020-01-31, per its 10-Q filed 2022-08-12.
Discontinued › Notes › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation › Business Combination, Recognized Asset Acquired to Liability Assumed, Excess (Less), and Goodwill › Business Combination, Recognized Asset Acquired to Liability Assumed, Excess (Less) › Business Combination, Recognized Liability Assumed, Liability
us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation · last filed 2022-08-12
- 2020-01-31: Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Lease Obligation $495.00K.
| Period end | Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Lease Obligation |
|---|---|
| 2020-01-31 | $495.00K 10-Q · filed 2022-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |